Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Benef Microbes ; 12(3): 295-305, 2021 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-33789553

RESUMEN

Bacteriocins have been steadily reported as potential agents that may contribute, in different ways, to overcome antimicrobial drug resistance. Here, holoxenic NMRI-F mice microbiota, their body weight recovery and histopathological alterations of organs like colon, spleen and liver were examined in mice intraperitoneally infected with 108 cfu of a clinical methicillin-resistant Staphylococcus aureus (MRSA-1), and treated with enterocin DD14 alone (165 mg/kg), erythromycin alone (100 mg/kg) or their combination. Animals that received both antimicrobials presented a better body weight recovery than other groups. Less pronounced histopathological alterations were observed in mice MRSA-infected and treated with bacteriocin than in those MRSA-infected but untreated or MRSA-infected and treated with erythromycin. Noteworthy, these alterations were absent when mice were treated with MRSA-infected and treated with both antibacterial agents. Furthermore, the genus richness was significantly lower in mice infected and treated with erythromycin, compared to mice infected and treated with both antimicrobials. The beta-diversity analysis showed that non-infected mice and those infected and treated with both antimicrobials, stand apart from the other groups as supported in a NMDS model. This in vivo study shows the relevance of bacteriocin, or bacteriocin-antibiotic formulation in protecting colonic, liver and spleen soft tissues and controlling the mouse gut microbiota, following MRSA infection.


Asunto(s)
Antibacterianos/uso terapéutico , Bacteriocinas/uso terapéutico , Peso Corporal/efectos de los fármacos , Microbioma Gastrointestinal/efectos de los fármacos , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Infecciones Estafilocócicas/tratamiento farmacológico , Animales , Colon/efectos de los fármacos , Colon/patología , Modelos Animales de Enfermedad , Quimioterapia Combinada , Heces/microbiología , Femenino , Microbioma Gastrointestinal/genética , Hígado/efectos de los fármacos , Hígado/patología , Ratones , Bazo/efectos de los fármacos , Bazo/patología , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/patología
2.
Angew Chem Int Ed Engl ; 38(16): 2391-2393, 1999 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10458797

RESUMEN

Unambiguous assignment of the resonances of different diastereomers in a nonracemic mixture is possible with (1)H-decoupled (2)H NMR spectroscopy in a chiral liquid crystalline solvent. This is demonstrated with, for example, the alpha,alpha'-dideuterated diol shown in the picture. Even diastereomers with centers of chirality up to nine bonds apart can be discriminated.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA